Obesity Weekly News - September 29th 2025
Obesity Update: Pfizer–Metsera Acquisition, Lilly’s $6.5B API Expansion, &…
Obesity Weekly News - September 23rd 2025
Obesity Update: ASC47 Combo Gains, Quintuple Agonist, Mazdutide Launch,…
Obesity Weekly News - September 16th 2025
Obesity Update: ASC30’s Ultra-Long Dosing, Oral GLP-1 Pill Race, Korea…
Obesity Weekly News - September 9th 2025
Obesity Updates: WHO EML GLP-1s, Orforglipron P3, Korea MOU and More…
Obesity Weekly News - September 2nd 2025
Viking’s Crash, Orforglipron’s Big Win, Wegovy vs Tirzepatide, Saxenda Generic…
Obesity Weekly News - August 26th 2025
Viking’s Crash, Orforglipron’s Rise, Semaglutide CV Data, SlimBiome Deal &…
Obesity Weekly News - August 19th 2025
Obesity Update: Enobosarm’s Oral Release, AI-Powered Drug Discovery, £85M…
Obesity Weekly News - August 12th 2025
Obesity Update: Ascletis’ ASC30, Hanmi’s CRF2 Breakthrough, Orforglipron’s…
Obesity Weekly News - August 5th 2025
Obesity Update: Radella’s MD-18, Korglutide’s Oral Entry, Liraglutide Launches,…
Obesity Weekly News - July 29th 2025
Obesity Update: Once-Monthly ASC30 Trial, Viking’s Phase III Launch, Generic…
Obesity Weekly News - July 22nd 2025
Obesity Update: CGX-926 Oral Debut, 18% Weight Loss from KAI-9531, Vivani’s…
Obesity Weekly News - July 15th 2025
Obesity Update: Wegovy’s 7.2mg Bid, Rhythm’s Oral Win, TRPV1 Breakthrough &…